Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become one of the most talked-about medications for weight management, with clinical trials showing average weight reductions of 10–15% over 68 weeks. Originally developed for type 2 diabetes, this GLP-1 receptor agonist now offers a new pathway for sustainable weight loss when combined with lifestyle changes. PlexusDx provides compounded semaglutide injections through licensed 503A compounding pharmacies, making access simple and affordable.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors in the brain and digestive system, triggering signals that reduce hunger and increase feelings of fullness. The medication slows stomach emptying, meaning food stays in your system longer and keeps you satisfied with smaller meals. By working on multiple appetite-control pathways simultaneously, semaglutide helps lower overall calorie intake without requiring intense willpower or constant food restriction.

The GLP-1 pathway also improves blood sugar stability, which can reduce cravings for high-calorie foods and energy crashes that often derail weight management efforts. Clinical data shows that participants on semaglutide consumed roughly 25–30% fewer daily calories compared to placebo groups. This natural appetite suppression makes it easier to maintain a calorie deficit, the fundamental requirement for sustained weight loss.

Expected Weight Loss Results and Timeline

Most people begin noticing appetite changes within the first 1–2 weeks of semaglutide treatment, though measurable weight loss typically appears by week 4. Average weight loss accelerates through weeks 8–16, with most patients reaching significant milestones by month 3. Over the full 68-week treatment period in major clinical trials, participants lost an average of 15 pounds at the 0.5 mg dose and up to 22 pounds at higher maintenance doses.

Individual results vary based on starting weight, genetic factors, adherence to diet and exercise, and metabolic differences. Some people experience faster initial weight loss in the first month, while others see steadier progress over weeks 6–12. PlexusDx offers the Precision Peptide Genetic Test to identify individual variations in GLP-1 receptor sensitivity and other peptide pathways, helping predict personal response patterns and optimize your treatment plan.

Common Side Effects and How to Manage Them

Nausea is the most frequently reported side effect, occurring in 25–35% of users in the first 1–2 weeks as the body adjusts to reduced food volume and slower digestion. Mild gastrointestinal symptoms including constipation, bloating, and reduced appetite for previously enjoyed foods are also common but typically resolve within 3–4 weeks. Starting at lower doses and increasing gradually allows the body to adapt, which significantly reduces the severity of these temporary effects.

Less common side effects include fatigue, headache, and changes in taste perception, most of which improve as treatment continues. Serious adverse events are rare but can include pancreatitis or gallbladder issues in susceptible individuals; discuss your personal and family medical history with your PlexusDx provider before starting. Staying hydrated, eating smaller frequent meals, and avoiding high-fat foods during the adjustment period can ease gastrointestinal discomfort substantially.

Semaglutide Injections vs. Oral Options and Cost

Semaglutide injections deliver the medication subcutaneously once weekly, allowing consistent blood levels and reliable appetite suppression throughout the week. PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A pharmacies, with no insurance requirement and HSA/FSA eligibility for additional savings. Oral semaglutide tablets offer a needle-free alternative starting at $249 per month, though injections typically produce more predictable absorption and faster results.

PlexusDx's pricing model keeps your monthly cost flat regardless of dose adjustments—your dose may need to go up, but your price won't increase. This transparent approach removes the guesswork and hidden costs found in traditional medical settings. Both injection and oral formulations are compounded at licensed 503A pharmacies meeting strict quality and sterility standards, ensuring safety and efficacy comparable to brand-name products.

Who Is a Good Candidate for Semaglutide Therapy

Semaglutide is most effective for adults with a BMI of 27 or higher, particularly those with weight-related health conditions like high blood pressure or type 2 diabetes. People who struggle with constant hunger, food cravings, or binge eating episodes often respond especially well because semaglutide directly addresses the neurological drivers of appetite. However, individuals with a personal or family history of thyroid cancer or pancreatitis should avoid semaglutide and discuss alternative options with their provider.

PlexusDx evaluates your full health history during the initial consultation to determine if semaglutide or an alternative GLP-1 medication like tirzepatide is the better choice for your unique situation. The Precision Peptide Genetic Test provides additional insight by mapping 49 peptides across 14 pathways, revealing genetic predispositions that influence how your body responds to GLP-1 therapy. This personalized approach ensures you receive the most effective medication and dose from the start.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see weight loss results from semaglutide?

Most patients notice reduced hunger within 1–2 weeks, but visible weight loss typically appears by week 4 and accelerates through weeks 8–16. Average weight loss at 68 weeks ranges from 15–22 pounds depending on dose and individual response, with PlexusDx monitoring your progress throughout treatment.

Is compounded semaglutide as effective as the brand-name version?

Yes—PlexusDx sources all semaglutide from licensed 503A compounding pharmacies that follow strict FDA guidelines for quality, sterility, and potency. The active ingredient and formulation are equivalent to brand-name products, though compounded medications are not FDA-approved and may be more affordable.

Can I use semaglutide if I have type 2 diabetes?

Semaglutide was originally developed for diabetes and is safe for dual use in weight management. Many patients with diabetes experience both improved blood sugar control and significant weight loss, making it an ideal dual-benefit option. Your PlexusDx provider will monitor blood sugar levels and adjust other medications as needed.

What happens if I stop taking semaglutide?

Weight may return gradually over several weeks to months without continued medication, though lifestyle changes and healthy habits adopted during treatment often help maintain some progress. PlexusDx recommends developing sustainable eating and exercise patterns while on semaglutide to support long-term success if you decide to discontinue.

How does the Precision Peptide Genetic Test improve semaglutide outcomes?

The test identifies genetic variations in your GLP-1 receptor and other peptide pathways (like FTO, MC4R, and GIPR) that predict your likely response to semaglutide versus alternatives like tirzepatide. This $99 add-on test helps PlexusDx select the optimal medication and starting dose, potentially improving results and reducing side effects from the beginning of treatment.

Does PlexusDx accept insurance for semaglutide treatment?

PlexusDx does not require insurance, with semaglutide injections starting at $149 per month across all 50 states. HSA and FSA accounts are accepted for additional tax-advantaged savings, making treatment accessible and affordable without navigating insurance approvals.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves